Apollo Endosurgery Stock Cash And Equivalents
| APENDelisted Stock | USD 10.00 0.00 0.00% |
Apollo Endosurgery fundamentals help investors to digest information that contributes to Apollo Endosurgery's financial success or failures. It also enables traders to predict the movement of Apollo Stock. The fundamental analysis module provides a way to measure Apollo Endosurgery's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apollo Endosurgery stock.
Apollo |
Apollo Endosurgery Company Cash And Equivalents Analysis
Apollo Endosurgery's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Apollo Endosurgery Cash And Equivalents | 74.74 M |
Most of Apollo Endosurgery's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollo Endosurgery is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Apollo Endosurgery has 74.74 M in Cash And Equivalents. This is 90.9% lower than that of the Health Care Equipment & Supplies sector and 86.6% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 97.23% higher than that of the company.
Apollo Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollo Endosurgery's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollo Endosurgery could also be used in its relative valuation, which is a method of valuing Apollo Endosurgery by comparing valuation metrics of similar companies.Apollo Endosurgery is currently under evaluation in cash and equivalents category among related companies.
Apollo Fundamentals
| Return On Equity | -0.85 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.52) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 400.85 M | |||
| Shares Outstanding | 47.55 M | |||
| Shares Owned By Insiders | 4.28 % | |||
| Shares Owned By Institutions | 63.40 % | |||
| Number Of Shares Shorted | 462.09 K | |||
| Price To Earning | (0.69) X | |||
| Price To Book | 9.78 X | |||
| Price To Sales | 5.78 X | |||
| Revenue | 76.86 M | |||
| Gross Profit | 42.43 M | |||
| EBITDA | (31.62 M) | |||
| Net Income | (39.84 M) | |||
| Cash And Equivalents | 74.74 M | |||
| Cash Per Share | 1.84 X | |||
| Total Debt | 33.96 M | |||
| Debt To Equity | 1.16 % | |||
| Current Ratio | 6.37 X | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | (31.26 M) | |||
| Short Ratio | 0.35 X | |||
| Earnings Per Share | (1.06) X | |||
| Target Price | 10.0 | |||
| Number Of Employees | 22 | |||
| Beta | 2.32 | |||
| Market Capitalization | 579.72 M | |||
| Total Asset | 110.23 M | |||
| Retained Earnings | (256.75 M) | |||
| Working Capital | 8.17 M | |||
| Current Asset | 9.25 M | |||
| Current Liabilities | 1.08 M | |||
| Z Score | 7.4 | |||
| Net Asset | 110.23 M |
About Apollo Endosurgery Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Endosurgery's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Endosurgery using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Endosurgery based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Apollo Endosurgery information on this page should be used as a complementary analysis to other Apollo Endosurgery's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Apollo Stock
If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |